Literature DB >> 24463963

Detection of free fatty acid receptor 1 expression: the critical role of negative and positive controls.

Charlott-Amelie Teutsch1, Madhura Panse, Manuel Grundmann, Gabriele Kaiser, Evi Kostenis, Hans-Ulrich Häring, Susanne Ullrich.   

Abstract

AIMS/HYPOTHESIS: Adequate evaluation of protein expression is a crucial prerequisite for functional studies. Commonly used strategies comprise detection of proteins by specific antibodies using western blotting and immunohistochemical staining, or detection of mRNA by in situ hybridisation and RT-PCR. We evaluated the tools for the detection of free fatty acid receptor 1 (FFAR1) expression.
METHODS: Commercially available antibody preparations were used to detect endogenous expression of the FFAR1 receptor and this was compared with cell preparations deficient or overexpressing the mouse or human receptor. Concentrations of mRNA were evaluated by RT-PCR.
RESULTS: All insulin-secreting cells, INS-1E, Min6 and mouse islets showed specific expression of Ffar1 at the mRNA level. However, none of the commercially available antibodies specifically detected rat, mouse or human FFAR1. CONCLUSIONS/
INTERPRETATION: Proper positive and negative controls are an important prerequisite for the evaluation of FFAR1 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463963     DOI: 10.1007/s00125-014-3161-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.

Authors:  Ralf Schröder; Nicole Janssen; Johannes Schmidt; Anna Kebig; Nicole Merten; Stephanie Hennen; Anke Müller; Stefanie Blättermann; Marion Mohr-Andrä; Sabine Zahn; Jörg Wenzel; Nicola J Smith; Jesús Gomeza; Christel Drewke; Graeme Milligan; Klaus Mohr; Evi Kostenis
Journal:  Nat Biotechnol       Date:  2010-08-15       Impact factor: 54.908

2.  Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.

Authors:  Annalisa Natalicchio; Rossella Labarbuta; Federica Tortosa; Giuseppina Biondi; Nicola Marrano; Alessandro Peschechera; Emanuele Carchia; Maura Roberta Orlando; Anna Leonardini; Angelo Cignarelli; Piero Marchetti; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2013-08-31       Impact factor: 10.122

3.  Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells.

Authors:  Ralf Schröder; Johannes Schmidt; Stefanie Blättermann; Lucas Peters; Nicole Janssen; Manuel Grundmann; Wiebke Seemann; Dorina Kaufel; Nicole Merten; Christel Drewke; Jesus Gomeza; Graeme Milligan; Klaus Mohr; Evi Kostenis
Journal:  Nat Protoc       Date:  2011-10-20       Impact factor: 13.491

Review 4.  The year in G protein-coupled receptor research.

Authors:  Robert P Millar; Claire L Newton
Journal:  Mol Endocrinol       Date:  2009-12-17

5.  Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.

Authors:  Yasuaki Itoh; Yuji Kawamata; Masataka Harada; Makoto Kobayashi; Ryo Fujii; Shoji Fukusumi; Kazuhiro Ogi; Masaki Hosoya; Yasuhiro Tanaka; Hiroshi Uejima; Hideyuki Tanaka; Minoru Maruyama; Rie Satoh; Shoichi Okubo; Hideki Kizawa; Hidetoshi Komatsu; Fumika Matsumura; Yuko Noguchi; Tokuyuki Shinohara; Shuji Hinuma; Yukio Fujisawa; Masahiko Fujino
Journal:  Nature       Date:  2003-02-23       Impact factor: 49.962

6.  Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability.

Authors:  Elisabeth Christiansen; Maria E Due-Hansen; Christian Urban; Manuel Grundmann; Johannes Schmidt; Steffen V F Hansen; Brian D Hudson; Mohamed Zaibi; Stine B Markussen; Ellen Hagesaether; Graeme Milligan; Michael A Cawthorne; Evi Kostenis; Matthias U Kassack; Trond Ulven
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

7.  Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system.

Authors:  Kazuo Nakamoto; Takashi Nishinaka; Kengo Matsumoto; Fumiyo Kasuya; Mitsumasa Mankura; Yutaka Koyama; Shogo Tokuyama
Journal:  Brain Res       Date:  2011-11-11       Impact factor: 3.252

8.  Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40.

Authors:  Johannes Schmidt; Kathrin Liebscher; Nicole Merten; Manuel Grundmann; Manfred Mielenz; Helga Sauerwein; Elisabeth Christiansen; Maria E Due-Hansen; Trond Ulven; Susanne Ullrich; Jesús Gomeza; Christel Drewke; Evi Kostenis
Journal:  J Biol Chem       Date:  2011-02-21       Impact factor: 5.157

9.  Redistribution of ADP-ribosylation factor during stimulation of permeabilized cells with GTP analogues.

Authors:  R Regazzi; S Ullrich; R A Kahn; C B Wollheim
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

10.  Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.

Authors:  Robert Wagner; Gabriele Kaiser; Felicia Gerst; Elisabeth Christiansen; Maria E Due-Hansen; Manuel Grundmann; Fausto Machicao; Andreas Peter; Evi Kostenis; Trond Ulven; Andreas Fritsche; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetes       Date:  2013-02-01       Impact factor: 9.461

  10 in total
  2 in total

1.  Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.

Authors:  Sibylle Sabrautzki; Gabriele Kaiser; Gerhard K H Przemeck; Felicia Gerst; Estela Lorza-Gil; Madhura Panse; Tina Sartorius; Miriam Hoene; Susan Marschall; Hans-Ulrich Häring; Martin Hrabě de Angelis; Susanne Ullrich
Journal:  Mol Metab       Date:  2017-07-18       Impact factor: 7.422

Review 2.  Lipid-Induced Adaptations of the Pancreatic Beta-Cell to Glucotoxic Conditions Sustain Insulin Secretion.

Authors:  Lucie Oberhauser; Pierre Maechler
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.